Copyright
©2005 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2005; 11(2): 228-231
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.228
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.228
Table 1 Relationship between FHIT expression and clinicopathological indices of HCC.
n | FHIT score | P | ||
- | + | |||
Age (yr) | ||||
≤45 | 18 | 10 | 8 | 0.658 |
>45 | 29 | 18 | 11 | |
Sex | ||||
Male | 38 | 21 | 18 | 0.278 |
Female | 9 | 7 | 2 | |
Histological grade | ||||
I-II | 39 | 21 | 18 | 0.119 |
III | 8 | 7 | 1 | |
TNM stage | ||||
I-II | 13 | 4 | 9 | 0.013 |
III-IV | 34 | 24 | 10 | |
Tumor size (diameter) | ||||
<50 mm | 19 | 12 | 7 | 0.68 |
≥50 mm | 28 | 16 | 12 | |
Extrahepatic metastasis | ||||
Positive | 15 | 13 | 2 | 0.01 |
Negative | 32 | 15 | 17 |
Table 2 Relationship between PI, AI and clinicopathological indices (mean±SD).
N | AI (%) | P value | PI (%) | P value | |
FHIT expression | |||||
Positive | 19 | 9.42±2.85 | 0.044 | 28.47±4.22 | 0.016 |
Negative | 28 | 8.07±1.63 | 31.61±4.24 | ||
Histological grade | |||||
I-II | 39 | 8.87±2.38 | 0.091 | 30.46±4.46 | 0.686 |
III | 8 | 7.38±1.19 | 29.75±4.74 | ||
TNM stage | |||||
I-II | 13 | 7.46±2.30 | 0.03 | 28.85±3.85 | 0.158 |
III-IV | 34 | 9.06±2.15 | 30.91±4.60 | ||
Tumor size (diameter) | |||||
<50 mm | 19 | 8.11±2.03 | 0.208 | 29.79±4.85 | 0.492 |
≥50 mm | 28 | 8.96±2.41 | 30.71±4.23 | ||
Extrahepatic metastasis | |||||
Positive | 15 | 9.00±1.89 | 0.436 | 32.53±3.93 | 0.019 |
Negative | 32 | 8.44±2.45 | 29.31±4.38 |
- Citation: Nan KJ, Ruan ZP, Jing Z, Qin HX, Wang HY, Guo H, Xu R. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis. World J Gastroenterol 2005; 11(2): 228-231
- URL: https://www.wjgnet.com/1007-9327/full/v11/i2/228.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i2.228